Lucid Diagnostics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

21.03.24	Lucid Diagnostics Gets Positive Data From Clinical Validation Study Of EsoGuard Esophageal DNA Test (RTTNews)
04.12.23	PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split (PR Newswire)
09.11.23	Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor Day (PR Newswire)
06.09.23	Lucid Diagnostics Releases Positive Data Demonstrating Clinical Utility of EsoGuard® Esophageal Precancer Detection in Fire Fighters (PR Newswire)
11.05.23	Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference (PR Newswire)
31.03.23	Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer (PR Newswire)
15.02.23	Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event (PR Newswire)
11.05.22	Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results (Businesswire)
09.05.22	Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans (Businesswire)
25.04.22	Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022 (Businesswire)
04.04.22	Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination (Businesswire)
30.03.22	Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference (Businesswire)
28.03.22	Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results (Businesswire)
24.03.22	PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study (Businesswire)
23.03.22	PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers (Businesswire)
07.03.22	Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022 (Businesswire)
04.03.22	Lucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech Summit (Businesswire)
03.03.22	PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth (Businesswire)
10.02.22	Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference (Businesswire)
19.01.22	Pre-market Movers: ZGNX, RVI, SOFI, VINE, CRDF… (RTTNews)
06.01.22	Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V